Negative influence of age on CD4+ cell recovery after highly active antiretroviral therapy in naïve HIV-1-infected patients with severe immunodeficiency

Journal of Infection

Volumn 56, Issue 2, 2008, Pages 130-136

  Micheloud, Dariela ^a   Berenguer, Juan ^a   Bellón, Jose M a ^a   Miralles, Pilar ^a   Cosin, Jaime ^a   Lopez Bernaldo de Quiros, Juan Carlos ^a   Conde, Matilde Sánchez ^a   Muñoz Fernández, M Ángeles ^a   Resino, Salvador ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Age; AIDS; CD4+; HAART; Recovery; Survival; Viral load

Indexed keywords

ABACAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; PROGNOSIS; RETROSPECTIVE STUDY; VIRUS LOAD;

ADULT; AGING; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 39049095046     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2007.12.001     Document Type: Article

References (22)

1. Epidemiology of HIV/AIDS-United States, 1981-2005. MMWR Morb Mortal Wkly Rep 55 21 (2006) 589-592
2. Berenguer J., Perez-Elias M.J., Bellon J.M., Knobel H., Rivas-Gonzalez P., Gatell J.M., et al. Effectiveness and safety of abacavir, lamivudine, and zidovudine in antiretroviral therapy-naive HIV-infected patients: results from a large multicenter observational cohort. J Acquir Immune Defic Syndr 41 2 (2006) 154-159
3. Pulido F., Arribas J.R., Miro J.M., Costa M.A., Gonzalez J., Rubio R., et al. Clinical, virologic, and immunologic response to efavirenz-or protease inhibitor-based highly active antiretroviral therapy in a cohort of antiretroviral-naive patients with advanced HIV infection (EfaVIP 2 study). J Acquir Immune Defic Syndr 35 4 (2004) 343-350
4. Pakker N.G., Notermans D.W., de Boer R.J., Roos M.T., de Wolf F., Hill A., et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 4 2 (1998) 208-214
5. Tumbarello M., Rabagliati R., de Gaetano Donati K., Bertagnolio S., Montuori E., Tamburrini E., et al. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis 4 (2004) 46
6. Harris J.M., Hazenberg M.D., Poulin J.F., Higuera-Alhino D., Schmidt D., Gotway M., et al. Multiparameter evaluation of human thymic function: interpretations and caveats. Clin Immunol 115 2 (2005) 138-146
7. Haynes B.F., Markert M.L., Sempowski G.D., Patel D.D., and Hale L.P. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu Rev Immunol 18 (2000) 529-560
8. CDC. Trends in HIV/AIDS Diagnoses-33 States, 2001-2004. MMWR Morb Mortal Wkly Rep 54 45 (2000) 1149-1153
9. Rosenberg P.S., Goedert J.J., and Biggar R.J. Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter Hemophilia Cohort Study and the International Registry of Seroconverters. AIDS 8 6 (1994) 803-810
10. Grabar S., Kousignian I., Sobel A., Le Bras P., Gasnault J., Enel P., et al. Immunologic and clinical responses to highly active antiretroviral therapy over 50 years of age. Results from the French Hospital Database on HIV. AIDS 18 15 (2004) 2029-2038
11. Carre N., Deveau C., Belanger F., Boufassa F., Persoz A., Jadand C., et al. Effect of age and exposure group on the onset of AIDS in heterosexual and homosexual HIV-infected patients. SEROCO Study Group. AIDS 8 6 (1994) 797-802
12. Skiest D.J., Rubinstien E., Carley N., Gioiella L., and Lyons R. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. Am J Med 101 6 (1996) 605-611
13. Darby S.C., Ewart D.W., Giangrande P.L., Spooner R.J., and Rizza C.R. Importance of age at infection with HIV-1 for survival and development of AIDS in UK haemophilia population. UK Haemophilia Centre Directors' Organisation. Lancet 347 9015 (1996) 1573-1579
14. Butt A.A., Dascomb K.K., DeSalvo K.B., Bazzano L., Kissinger P.J., and Szerlip H.M. Human immunodeficiency virus infection in elderly patients. South Med J 94 4 (2001) 397-400
15. Goodkin K., Shapshak P., Asthana D., Zheng W., Concha M., Wilkie F.L., et al. Older age and plasma viral load in HIV-1 infection. AIDS 18 Suppl. 1 (2004) S87-S98
16. Cohen Stuart J., Hamann D., Borleffs J., Roos M., Miedema F., Boucher C., et al. Reconstitution of naive T cells during antiretroviral treatment of HIV-infected adults is dependent on age. AIDS 16 17 (2002) 2263-2266
17. Viard J.P., Mocroft A., Chiesi A., Kirk O., Roge B., Panos G., et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J Infect Dis 183 8 (2001) 1290-1294
18. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396 6712 (1998) 690-695
19. McCune J.M., Hanley M.B., Cesar D., Halvorsen R., Hoh R., Schmidt D., et al. Factors influencing T-cell turnover in HIV-1-seropositive patients. J Clin Invest 105 5 (2000) R1-R8
20. Kaufmann G.R., Bloch M., Finlayson R., Zaunders J., Smith D., and Cooper D.A. The extent of HIV-1-related immunodeficiency and age predict the long- term CD4 T lymphocyte response to potent antiretroviral therapy. AIDS 16 3 (2002) 359-367
21. Le Moing V., Thiebaut R., Chene G., Leport C., Cailleton V., Michelet C., et al. Predictors of long-term increase in CD4(+) cell counts in human immunodeficiency virus-infected patients receiving a protease inhibitor-containing antiretroviral regimen. J Infect Dis 185 4 (2002) 471-480
22. Tarwater P.M., Margolick J.B., Jin J., Phair J.P., Detels R., Rinaldo C., et al. Increase and plateau of CD4 T-cell counts in the 3(1/2) years after initiation of potent antiretroviral therapy. J Acquir Immune Defic Syndr 27 2 (2001) 168-175